Infliximab dramatically clears severe psoriasis


New Orleans - The experience of a teenage girl treated successfully with infliximab (Remicade) for severe, recalcitrant psoriasis of her hands and feet indicates the value of the TNF-alpha chimeric monoclonal antibody as a therapeutic option for psoriasis.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.